MAPT and supranuclear palsy, progressive, 1: Recent studies have emphasized, however, that CBD and PSP tau show distinguishable molecular characteristics43–45, hence it will be important in future studies to assess whether molecular differences in CBD and PSP tau modulate the spreading potential of tau pathology.